Holen Sie sich die Stockscreener-App
3.495
11.66%
0.365
Schlusskurs vom Vortag:
$3.13
Offen:
$3.2
24-Stunden-Volumen:
94,139
Relative Volume:
1.04
Marktkapitalisierung:
$16.93M
Einnahmen:
$8,700
Nettoeinkommen (Verlust:
$-8.49M
KGV:
-0.7089
EPS:
-4.9303
Netto-Cashflow:
$-7.39M
1W Leistung:
+15.73%
1M Leistung:
-25.32%
6M Leistung:
+67.22%
1J Leistung:
+3.40%
1-Tages-Spanne:
$3.20
$3.599
1-Wochen-Bereich:
$2.89
$3.3199
52-Wochen-Spanne:
$1.63
$5.25
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.495 | 16.93M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
98.70 | 170.80B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.48 | 119.57B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.20 | 64.05B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.80 | 50.61B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
One seller would hold about 94% of voting power after HeartSciences (HSCS)' proposed merger. - Stock Titan
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device (K260005) - Kalkine Media
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device Under K260005 - Kalkine Media
HeartSciences Submits Supplemental Proxy Materials Detailing Fortitude Merger and New Legal Appointment - Kalkine Media
Form S-3 HEARTSCIENCES INC. For: 25 September By Investing.com - Investing.com Canada
HeartSciences Warrant (HSCSW) Climbs 25.17% to $0.05 in Sub-Penny TradingATR Stop - dars.gov.et
HeartSciences (NASDAQ: HSCS) asks investors to back a shift into crypto mining - Stock Titan
HeartSciences Widens Q1 Loss to $3.2 Million as wavECG Device Is Shelved - Minichart
HSCS 8-K FilingsHeartSciences Inc. SEC 8-K - Stock Titan
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update - The Manila Times
HeartSciences posts $3.2M loss, cash down to $29.9K - Stock Titan
HSCS Q1'26 Earnings: EPS estimate is (0.72) USD - TradingView
HSCS Q1'26 Earnings: revenue estimate is 0 USD - TradingView
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionPositive Gamma - vinanet.vn
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionSMA Signal - dars.gov.et
HeartSciences(HSCS) Stock Options Chain | Quotes & News - Moomoo
Fortitude invests USD 1M in HeartSciences - Medical Buyer
Fortitude Mining Invests in HeartSciences Ahead Planned Merger - TipRanks
HeartSciences: Fortitude buys $1.0M of stock, merger on track as Fortitude posts $20.9M revenue, $8.5M adj. EBITDA - TradingView
Fortitude Mining reports $21M Q2 revenue and plots public listing via reverse merger - Crypto Briefing
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - marketscreener.com
Press Release: Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - Moomoo
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - businesswire.com
HeartSciences and Fortitude Mining Sign Definitive All-Stock Merger Agreement - Minichart
Form 8K HeartSciences Inc For: 19 August By Investing.com - Investing.com Nigeria
Fortitude Now Holds About 9.4% of HeartSciences' Outstanding Shares of Common Stock >HSCS - Moomoo
Fortitude Investment Strengthens HeartSciences Ahead Planned Merger - TipRanks
BRIEF-Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - Bitget
[8-K/A] HeartSciences Inc. Amends Material Event Report - Stock Titan
Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - TradingView
HeartSciences Announces $1 Million Fortitude Investment at 22% Premium Ahead of Proposed Merger - Quiver Quantitative
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingFinal Results - vinanet.vn
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingRevenue Growth Report - Vinanet
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingEstimate Dispersion - dars.gov.et
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration - The Manila Times
HeartSciences sells 411,522 shares to Fortitude in $1 million private placement at $2.43 each - Bitget
DCG stake sets up voting control of HeartSciences (HSCS) - Stock Titan
Digital Currency Group Discloses Investment at HeartSciences with 9.4% Stake - TradingView
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com South Africa
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Nigeria
HeartSciences Completes Private Placement to Support Merger - TipRanks
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com India
HeartSciences (HSCS) Holds Steady at $2.06 as Shares FlatlineETF Premium Discount - vinanet.vn
HeartSciences Inc (HSCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HeartSciences Inc. (HSCS) Holds at $2.02 After 1.00% Gain as Key Levels Remain in FocusSentiment Shift - dars.gov.et
HSCS Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue AI-ECG BurnRevenue Inflection Point - vinanet.vn
HeartSciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
HeartSciences Inc. Revenue Breakdown – BOATS:HSCSW - TradingView
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
6.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):